![Vikas Goyal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vikas Goyal
Corporate Officer/Principal presso
PANDION THERAPEUTICS, INC.
Profilo
Vikas Goyal is the founder of Extera Partners LLC, founded in 2006.
Current jobs include Director at Gladius Pharmaceuticals, Inc., Director at Morphic Therapeutic, Inc., Member at Society of Kauffman Fellows, Partner at Longwood Fund Management LLC starting 2025, Senior Vice President-Business Development at Pandion Operations, Inc. since 2019, and Senior Vice President-Business Development at Pandion Therapeutics, Inc. since 2019.
Former jobs include Director at CalciMedica Subsidiary, Inc., Director at Nimbus Therapeutics LLC, Director at Zikani Therapeutics, Inc., Director at Spero Therapeutics, Inc. from 2013 to 2018, Independent Director at Morphic Holding, Inc. from 2016 to 2021, Consultant at McKinsey & Co., Inc., Principal at GSK Equity Investments Ltd from 2011 to 2019, and Manager-Business Development at Infinity Pharmaceuticals, Inc. Education includes an undergraduate degree from Harvard University in 2001 and an MBA from The Wharton School of the University of Pennsylvania in 2010.
Posizioni attive di Vikas Goyal
| Società | Posizione | Inizio |
|---|---|---|
| PANDION THERAPEUTICS, INC. | Corporate Officer/Principal | 01/08/2019 |
Society of Kauffman Fellows
 Society of Kauffman Fellows Miscellaneous Commercial ServicesCommercial Services Operates as a network of venture capitalists | Corporate Officer/Principal | - |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors | Direttore/Membro del Consiglio | - |
Gladius Pharmaceuticals, Inc.
 Gladius Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops biotechnology novel drugs | Direttore/Membro del Consiglio | - |
Pandion Operations, Inc.
 Pandion Operations, Inc. Miscellaneous Commercial ServicesCommercial Services Develops drugs for autoimmune, inflammatory and transplant indications | Corporate Officer/Principal | 17/07/2019 |
Longwood Fund Management LLC
 Longwood Fund Management LLC Investment ManagersFinance Longwood Fund invests in companies located in the United States. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Investitore di Private Equity | 01/08/2024 |
Precedenti posizioni note di Vikas Goyal
| Società | Posizione | Fine |
|---|---|---|
| MORC HOLD | Direttore/Membro del Consiglio | 16/06/2021 |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Investitore di Private Equity | 01/07/2019 |
| SPERO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/02/2018 |
| ░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ | - |
Formazione di Vikas Goyal
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
92
Relazioni di 1° grado
17
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 17 |
|---|---|
CalciMedica Subsidiary, Inc.
 CalciMedica Subsidiary, Inc. BiotechnologyHealth Technology Engages in drug development | Health Technology |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Operates as a clinical stage biotech company that develops molecule medicines for diseases like cancer, immune disorders and metabolic conditions | Health Technology |
Zikani Therapeutics, Inc.
 Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Focuses on the discovery and development of novel macrolide antibiotics for the treatment of life-threatening bacterial infections caused by drug resistant pathogens | Retail Trade |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Finance |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
Society of Kauffman Fellows
Society of Kauffman Fellows Miscellaneous Commercial ServicesCommercial Services Operates as a network of venture capitalists | Commercial Services |
Extera Partners LLC
 Extera Partners LLC Miscellaneous Commercial ServicesCommercial Services Provides business advisory services | Commercial Services |
Longwood Fund Management LLC
Longwood Fund Management LLC Investment ManagersFinance Longwood Fund invests in companies located in the United States. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Finance |
Spero Therapeutics, Inc.
 Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gladius Pharmaceuticals, Inc.
Gladius Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops biotechnology novel drugs | Health Technology |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors | Health Technology |
Morphic Holding, Inc.
 Morphic Holding, Inc. Pharmaceuticals: MajorHealth Technology Develops oral integrin drugs | Health Technology |
Pandion Operations, Inc.
Pandion Operations, Inc. Miscellaneous Commercial ServicesCommercial Services Develops drugs for autoimmune, inflammatory and transplant indications | Commercial Services |
Pandion Therapeutics, Inc.
 Pandion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company which develops novel therapeutics for autoimmune diseases | Health Technology |
